APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Medicine and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Porcine Medicine and Vaccines Market Analysis and Forecast 2026-2032

2 January 2026205 pages

Choose your research edition.

Industry ResearchPorcine Medicine and Vaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Medicine and Vaccines Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Porcine Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Medicine and Vaccines Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Medicine and Vaccines Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Porcine Medicine and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Porcine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Porcine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Porcine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Porcine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Porcine Medicine and Vaccines include Merck, Jinyu Bio-Technology, ChengDu Tecbond, Zoetis, WINSUN, Virbac, Tecon, Ringpu Biology and HVRI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Porcine Medicine and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Porcine Medicine and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Porcine Medicine and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Porcine Medicine and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Porcine Medicine and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Porcine Medicine and Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Porcine Medicine and Vaccines Segment by Company

Merck

Jinyu Bio-Technology

ChengDu Tecbond

Zoetis

WINSUN

Virbac

Tecon

Ringpu Biology

HVRI

Hipra

Hile Bio

DHN

Chopper Biology

Ceva

CAVAC

CAHIC

Boehringer Ingelheim

Bioveta

Porcine Medicine and Vaccines Segment by Type

Medicine

Vaccines

Porcine Medicine and Vaccines Segment by Application

Government Tender

Market Sales

Porcine Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Porcine Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Porcine Medicine and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Porcine Medicine and Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Porcine Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medicine Major Player Table 3. Vaccines Major Player Table 4. Global Porcine Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government Tender Major Player Table 6. Market Sales Major Player Table 7. Porcine Medicine and Vaccines Industry Trends Table 8. Porcine Medicine and Vaccines Industry Drivers Table 9. Porcine Medicine and Vaccines Industry Opportunities and Challenges Table 10. Porcine Medicine and Vaccines Industry Restraints Table 11. Global Porcine Medicine and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Porcine Medicine and Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Porcine Medicine and Vaccines Market Share by Region (2021-2026) Table 14. Global Porcine Medicine and Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Porcine Medicine and Vaccines Market Share by Region (2027-2032) Table 16. Global Porcine Medicine and Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Porcine Medicine and Vaccines Revenue Market Share by Players (2021-2026) Table 18. Global Porcine Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Porcine Medicine and Vaccines Key Players Headquarters & Area Served Table 20. Global Porcine Medicine and Vaccines Players, Product Type & Application Table 21. Global Porcine Medicine and Vaccines Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Porcine Medicine and Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Porcine Medicine and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Porcine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Porcine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Porcine Medicine and Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Porcine Medicine and Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global Porcine Medicine and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Porcine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Porcine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Porcine Medicine and Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global Porcine Medicine and Vaccines Revenue Market Share by Application (2027-2032) Table 34. Merck Company Information Table 35. Merck Business Overview Table 36. Merck Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Merck Porcine Medicine and Vaccines Product Portfolio Table 38. Merck Recent Development Table 39. Jinyu Bio-Technology Company Information Table 40. Jinyu Bio-Technology Business Overview Table 41. Jinyu Bio-Technology Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Jinyu Bio-Technology Porcine Medicine and Vaccines Product Portfolio Table 43. Jinyu Bio-Technology Recent Development Table 44. ChengDu Tecbond Company Information Table 45. ChengDu Tecbond Business Overview Table 46. ChengDu Tecbond Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. ChengDu Tecbond Porcine Medicine and Vaccines Product Portfolio Table 48. ChengDu Tecbond Recent Development Table 49. Zoetis Company Information Table 50. Zoetis Business Overview Table 51. Zoetis Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Zoetis Porcine Medicine and Vaccines Product Portfolio Table 53. Zoetis Recent Development Table 54. WINSUN Company Information Table 55. WINSUN Business Overview Table 56. WINSUN Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. WINSUN Porcine Medicine and Vaccines Product Portfolio Table 58. WINSUN Recent Development Table 59. Virbac Company Information Table 60. Virbac Business Overview Table 61. Virbac Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Virbac Porcine Medicine and Vaccines Product Portfolio Table 63. Virbac Recent Development Table 64. Tecon Company Information Table 65. Tecon Business Overview Table 66. Tecon Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Tecon Porcine Medicine and Vaccines Product Portfolio Table 68. Tecon Recent Development Table 69. Ringpu Biology Company Information Table 70. Ringpu Biology Business Overview Table 71. Ringpu Biology Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Ringpu Biology Porcine Medicine and Vaccines Product Portfolio Table 73. Ringpu Biology Recent Development Table 74. HVRI Company Information Table 75. HVRI Business Overview Table 76. HVRI Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. HVRI Porcine Medicine and Vaccines Product Portfolio Table 78. HVRI Recent Development Table 79. Hipra Company Information Table 80. Hipra Business Overview Table 81. Hipra Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Hipra Porcine Medicine and Vaccines Product Portfolio Table 83. Hipra Recent Development Table 84. Hile Bio Company Information Table 85. Hile Bio Business Overview Table 86. Hile Bio Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hile Bio Porcine Medicine and Vaccines Product Portfolio Table 88. Hile Bio Recent Development Table 89. DHN Company Information Table 90. DHN Business Overview Table 91. DHN Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. DHN Porcine Medicine and Vaccines Product Portfolio Table 93. DHN Recent Development Table 94. Chopper Biology Company Information Table 95. Chopper Biology Business Overview Table 96. Chopper Biology Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Chopper Biology Porcine Medicine and Vaccines Product Portfolio Table 98. Chopper Biology Recent Development Table 99. Ceva Company Information Table 100. Ceva Business Overview Table 101. Ceva Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Ceva Porcine Medicine and Vaccines Product Portfolio Table 103. Ceva Recent Development Table 104. CAVAC Company Information Table 105. CAVAC Business Overview Table 106. CAVAC Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. CAVAC Porcine Medicine and Vaccines Product Portfolio Table 108. CAVAC Recent Development Table 109. CAHIC Company Information Table 110. CAHIC Business Overview Table 111. CAHIC Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. CAHIC Porcine Medicine and Vaccines Product Portfolio Table 113. CAHIC Recent Development Table 114. Boehringer Ingelheim Company Information Table 115. Boehringer Ingelheim Business Overview Table 116. Boehringer Ingelheim Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Boehringer Ingelheim Porcine Medicine and Vaccines Product Portfolio Table 118. Boehringer Ingelheim Recent Development Table 119. Bioveta Company Information Table 120. Bioveta Business Overview Table 121. Bioveta Porcine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Bioveta Porcine Medicine and Vaccines Product Portfolio Table 123. Bioveta Recent Development Table 124. North America Porcine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Porcine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Porcine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Porcine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Porcine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Porcine Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Porcine Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Porcine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Porcine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Porcine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Porcine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Porcine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Porcine Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Porcine Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 138. China Porcine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 139. China Porcine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 140. China Porcine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 141. China Porcine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Porcine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Porcine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Porcine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Porcine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Porcine Medicine and Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Porcine Medicine and Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Porcine Medicine and Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Porcine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Porcine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Porcine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Porcine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Porcine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Porcine Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Porcine Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Porcine Medicine and Vaccines Image Figure 2. Global Porcine Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicine Image Figure 5. Vaccines Image Figure 6. Global Porcine Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Porcine Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government Tender Image Figure 9. Market Sales Image Figure 10. Global Porcine Medicine and Vaccines Market Size (US$ Million) & (2021-2032) Figure 11. Global Porcine Medicine and Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Porcine Medicine and Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Porcine Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Porcine Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Porcine Medicine and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Porcine Medicine and Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Global Porcine Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Porcine Medicine and Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Porcine Medicine and Vaccines Revenue Market Share by Application (2021-2032) Figure 21. North America Porcine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Porcine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 23. North America Porcine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 24. North America Porcine Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 25. United States Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Porcine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Porcine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 30. Europe Porcine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 31. Europe Porcine Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 32. Germany Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Porcine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Porcine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 42. China Porcine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 43. Asia Porcine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Porcine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 45. Asia Porcine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 46. Asia Porcine Medicine and Vaccines Revenue Share by Region (2021-2032) Figure 47. Japan Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Porcine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Porcine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 55. SAMEA Porcine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 56. SAMEA Porcine Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 57. Brazil Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Porcine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • Merck
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • Zoetis
  • WINSUN
  • Virbac
  • Tecon
  • Ringpu Biology
  • HVRI
  • Hipra
  • Hile Bio
  • DHN
  • Chopper Biology
  • Ceva
  • CAVAC
  • CAHIC
  • Boehringer Ingelheim
  • Bioveta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Porcine Medicine and Vaccines Market by Type
  3. 1.2.1 Global Porcine Medicine and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medicine
  5. 1.2.3 Vaccines
  6. 1.3 Porcine Medicine and Vaccines Market by Application
  7. 1.3.1 Global Porcine Medicine and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Government Tender
  9. 1.3.3 Market Sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Porcine Medicine and Vaccines Market Dynamics
  1. 2.1 Porcine Medicine and Vaccines Industry Trends
  2. 2.2 Porcine Medicine and Vaccines Industry Drivers
  3. 2.3 Porcine Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Porcine Medicine and Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Porcine Medicine and Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Porcine Medicine and Vaccines Growth Trends by Region
  3. 3.2.1 Global Porcine Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Porcine Medicine and Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Porcine Medicine and Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Porcine Medicine and Vaccines Revenue by Players
  2. 4.1.1 Global Porcine Medicine and Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Porcine Medicine and Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Porcine Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Porcine Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Porcine Medicine and Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Porcine Medicine and Vaccines Players, Product Type & Application
  8. 4.5 Global Porcine Medicine and Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Porcine Medicine and Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Porcine Medicine and Vaccines Tier 1, Tier 2, and Tier 3
5 Porcine Medicine and Vaccines Market Size by Type
  1. 5.1 Global Porcine Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Porcine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Porcine Medicine and Vaccines Revenue Market Share by Type (2021-2032)
6 Porcine Medicine and Vaccines Market Size by Application
  1. 6.1 Global Porcine Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Porcine Medicine and Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Porcine Medicine and Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Porcine Medicine and Vaccines Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Jinyu Bio-Technology
  8. 7.2.1 Jinyu Bio-Technology Company Information
  9. 7.2.2 Jinyu Bio-Technology Business Overview
  10. 7.2.3 Jinyu Bio-Technology Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Jinyu Bio-Technology Porcine Medicine and Vaccines Product Portfolio
  12. 7.2.5 Jinyu Bio-Technology Recent Developments
  13. 7.3 ChengDu Tecbond
  14. 7.3.1 ChengDu Tecbond Company Information
  15. 7.3.2 ChengDu Tecbond Business Overview
  16. 7.3.3 ChengDu Tecbond Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ChengDu Tecbond Porcine Medicine and Vaccines Product Portfolio
  18. 7.3.5 ChengDu Tecbond Recent Developments
  19. 7.4 Zoetis
  20. 7.4.1 Zoetis Company Information
  21. 7.4.2 Zoetis Business Overview
  22. 7.4.3 Zoetis Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Zoetis Porcine Medicine and Vaccines Product Portfolio
  24. 7.4.5 Zoetis Recent Developments
  25. 7.5 WINSUN
  26. 7.5.1 WINSUN Company Information
  27. 7.5.2 WINSUN Business Overview
  28. 7.5.3 WINSUN Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 WINSUN Porcine Medicine and Vaccines Product Portfolio
  30. 7.5.5 WINSUN Recent Developments
  31. 7.6 Virbac
  32. 7.6.1 Virbac Company Information
  33. 7.6.2 Virbac Business Overview
  34. 7.6.3 Virbac Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Virbac Porcine Medicine and Vaccines Product Portfolio
  36. 7.6.5 Virbac Recent Developments
  37. 7.7 Tecon
  38. 7.7.1 Tecon Company Information
  39. 7.7.2 Tecon Business Overview
  40. 7.7.3 Tecon Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Tecon Porcine Medicine and Vaccines Product Portfolio
  42. 7.7.5 Tecon Recent Developments
  43. 7.8 Ringpu Biology
  44. 7.8.1 Ringpu Biology Company Information
  45. 7.8.2 Ringpu Biology Business Overview
  46. 7.8.3 Ringpu Biology Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ringpu Biology Porcine Medicine and Vaccines Product Portfolio
  48. 7.8.5 Ringpu Biology Recent Developments
  49. 7.9 HVRI
  50. 7.9.1 HVRI Company Information
  51. 7.9.2 HVRI Business Overview
  52. 7.9.3 HVRI Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 HVRI Porcine Medicine and Vaccines Product Portfolio
  54. 7.9.5 HVRI Recent Developments
  55. 7.10 Hipra
  56. 7.10.1 Hipra Company Information
  57. 7.10.2 Hipra Business Overview
  58. 7.10.3 Hipra Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Hipra Porcine Medicine and Vaccines Product Portfolio
  60. 7.10.5 Hipra Recent Developments
  61. 7.11 Hile Bio
  62. 7.11.1 Hile Bio Company Information
  63. 7.11.2 Hile Bio Business Overview
  64. 7.11.3 Hile Bio Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Hile Bio Porcine Medicine and Vaccines Product Portfolio
  66. 7.11.5 Hile Bio Recent Developments
  67. 7.12 DHN
  68. 7.12.1 DHN Company Information
  69. 7.12.2 DHN Business Overview
  70. 7.12.3 DHN Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 DHN Porcine Medicine and Vaccines Product Portfolio
  72. 7.12.5 DHN Recent Developments
  73. 7.13 Chopper Biology
  74. 7.13.1 Chopper Biology Company Information
  75. 7.13.2 Chopper Biology Business Overview
  76. 7.13.3 Chopper Biology Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Chopper Biology Porcine Medicine and Vaccines Product Portfolio
  78. 7.13.5 Chopper Biology Recent Developments
  79. 7.14 Ceva
  80. 7.14.1 Ceva Company Information
  81. 7.14.2 Ceva Business Overview
  82. 7.14.3 Ceva Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Ceva Porcine Medicine and Vaccines Product Portfolio
  84. 7.14.5 Ceva Recent Developments
  85. 7.15 CAVAC
  86. 7.15.1 CAVAC Company Information
  87. 7.15.2 CAVAC Business Overview
  88. 7.15.3 CAVAC Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CAVAC Porcine Medicine and Vaccines Product Portfolio
  90. 7.15.5 CAVAC Recent Developments
  91. 7.16 CAHIC
  92. 7.16.1 CAHIC Company Information
  93. 7.16.2 CAHIC Business Overview
  94. 7.16.3 CAHIC Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  95. 7.16.4 CAHIC Porcine Medicine and Vaccines Product Portfolio
  96. 7.16.5 CAHIC Recent Developments
  97. 7.17 Boehringer Ingelheim
  98. 7.17.1 Boehringer Ingelheim Company Information
  99. 7.17.2 Boehringer Ingelheim Business Overview
  100. 7.17.3 Boehringer Ingelheim Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Boehringer Ingelheim Porcine Medicine and Vaccines Product Portfolio
  102. 7.17.5 Boehringer Ingelheim Recent Developments
  103. 7.18 Bioveta
  104. 7.18.1 Bioveta Company Information
  105. 7.18.2 Bioveta Business Overview
  106. 7.18.3 Bioveta Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Bioveta Porcine Medicine and Vaccines Product Portfolio
  108. 7.18.5 Bioveta Recent Developments
8 North America
  1. 8.1 North America Porcine Medicine and Vaccines Revenue (2021-2032)
  2. 8.2 North America Porcine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Porcine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Porcine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Porcine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Porcine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Porcine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Porcine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Porcine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Porcine Medicine and Vaccines Revenue by Country
  11. 8.6.1 North America Porcine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Porcine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Porcine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Porcine Medicine and Vaccines Revenue (2021-2032)
  2. 9.2 Europe Porcine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Porcine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Porcine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Porcine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Porcine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Porcine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Porcine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Porcine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Porcine Medicine and Vaccines Revenue by Country
  11. 9.6.1 Europe Porcine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Porcine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Porcine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Porcine Medicine and Vaccines Revenue (2021-2032)
  2. 10.2 China Porcine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Porcine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Porcine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Porcine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Porcine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Porcine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Porcine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Porcine Medicine and Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Porcine Medicine and Vaccines Revenue (2021-2032)
  2. 11.2 Asia Porcine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Porcine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Porcine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Porcine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Porcine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Porcine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Porcine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Porcine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Porcine Medicine and Vaccines Revenue by Country
  11. 11.6.1 Asia Porcine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Porcine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Porcine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Porcine Medicine and Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Porcine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Porcine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Porcine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Porcine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Porcine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Porcine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Porcine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Porcine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Porcine Medicine and Vaccines Revenue by Country
  11. 12.6.1 SAMEA Porcine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Porcine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Porcine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst